Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994

British Journal of Clinical Pharmacology

Volumn 41, Issue 4, 1996, Pages 285-289

  Gaist, David ^a   Hallas, Jesper ^a   Hansen, Niels Chr G ^b   Gram, Lars F ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anti asthma drugs; Asthma bronchiale; Inhaled corticosteroids; Pharmacoepidemiology

Indexed keywords

BAMBUTEROL; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUTICASONE; IPRATROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; DATA BASE; DRUG USE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0029929250     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03154.x     Document Type: Article

References (18)

1. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992. Eur Respir J 1992; 5: 601-641.
2. Guidelines for the management of asthma: a summary. British Thoracic Society and others. Br Med J 1993; 306: 776-782.
3. Hallas J, Hansen N-CG Individual utilization of anti-asthma medication by young adults: a prescription database analysis. J Intern Med 1993; 234: 65-70.
4. Population in municipalities 1991 to 1994 [In Danish], Copenhagen, 1995.
5. Nordic Council of Medicine, (1985) Nordic drug index with defined daily doses. Nordic statistics on medicine 1981-83 part 2.
6. Laursen LC, Iversen E [Use of antiasthmatic agents in Denmark during 1979-1989. Do we overuse antiasthmatic drugs?]. Ugeskr Laeger 1991; 153: 1881-1882.
7. Gerstman BB, Bosco LA, Tomita DK, Gross TP, Shaw MM. Prevalence and treatment of asthma in the Michigan Medicaid patient population younger than 45 years, 1980-1986. J Allergy Clin Immunol 1989; 83: 1032-1039.
8. Kesten S, Rebuck AS, Chapman KR. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990. J Allergy Clin Immunol 1993; 92: 499-506.
9. Keating G, Mitchell EA, Jackson R, Beaglehole R, Rea H. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J Clin Res Ed 1984; 289: 348-351.
10. Jenkins MA, Hurley SF, Bowes G, McNeil JJ. Use of antiasthmatic drugs in Australia. Med J Aust 1990; 153: 323-328.
11. McManus P, Birkett D. Recent trends in the use of antiasthmatic drugs. Med J Aust 1993; 159: 832-833.
12. The Audit Commission, (1994) A prescription for improvement, London, HMSO.
13. Warner JO. Review of prescribed treatment for children with asthma in 1990. Br Med J 1995; 311: 663-666.
14. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501-506.
15. Buist AS, Vollmer WM Preventing deaths from asthma. N Engl J Med 1994; 331: 1584-1585.
16. Horn CR, Clark TJ, Cochrane GM. Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective study. Respir Med 1990; 84: 61-66.
17. Zeiger RS, Heller S, Mellon MH, Wald J, Falkoff R, Schatz M. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Allergy Clin Immunol 1991; 87: 1160-1168.
18. Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med 1990; 112: 864-871.